G. Cusano

The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines.

H. Koeffler, G. Scambia, C. Ferlini, 2004, Oncology research.

Resistance to the atypical retinoid ST1926 in SK-N-AS cells selected the subline rAS-ST with enhanced sensitivity to ATRA mediated by not conventional mechanisms: DNA damage, G2 accumulation and late telomerase inhibition.

M. Falconi, R. Riccardi, I. Orienti, 2015, Toxicology in vitro : an international journal published in association with BIBRA.

Enhanced cell cycle perturbation and apoptosis mediate the synergistic effects of ST1926 and ATRA in neuroblastoma preclinical models

P. Ubezio, M. D’Incalci, R. Riccardi, 2012, Investigational New Drugs.

hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF

L. Levati, R. Riccardi, O. Franzese, 2021, Pathology & Oncology Research.

Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts

M. Zucchetti, M. D’Incalci, V. Patriarca, 2010, Cancer Chemotherapy and Pharmacology.

Preclinical evaluation of the novel 7-substituted camptothecin Namitecan (ST1968) in paediatric tumour models

V. Patriarca, R. Riccardi, F. Bucci, 2012, Cancer Chemotherapy and Pharmacology.

Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.

F. Giangaspero, R. Riccardi, C. Ferlini, 2009, Neuro-oncology.

Nanoencapsulation of Fenretinide in Glucosamine Butyrate - GelatinMatrices as a Mean to Improve its Oral Bioavailability

M. Zucchetti, R. Gotti, M. Falconi, 2015 .

Monoclonal antibodies to the cell surface of a unique human lymphoid/myeloid cell line detect epitopes absent from peripheral blood mononuclear cells.

D. A. Russo, C. August, J. Bash, 1997, Transplantation Proceedings.

Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo.

F. Giangaspero, R. Riccardi, C. Ferlini, 2009, Neuro-oncology.